TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) Investor Securities Class Action Lawsuit 10/01/2014

  • If you purchased shares of AcelRx Pharmaceuticals Inc (NASDAQ: ACRX), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

January 18, 2016 - The court dismissed the case with prejudice. November 25, 2015 - The court granted defendants' motion to dismiss with leave to amend. June 2, 2015 - Defendants filed a motion to dismiss. April 17, 2015 - The lead plaintiff filed an amended complaint. March 16, 2015 - On March 9, 2015, AcelRx Pharmaceuticals Inc provided an update on the timing and potential con...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: